Related Experiment Video
Updated: Jun 5, 2026
Isolation & Characterization of Hoechstlow CD45negative Mouse Lung Mesenchymal Stem Cells
Published on: October 26, 2011
Inhibition of lung cancer cell proliferation mediated by human mesenchymal stem cells
Lin Li1, Hui Tian, Zhitao Chen
1Department of Thoracic Surgery, Qilu Hospital, Shandong University, Jinan, China.
Abstract:
Human mesenchymal stem cells (hMSCs) are mostly studied for their potential clinical use. Recently, much attention in the field of cancer research has been paid to hMSCs. In this study, we investigated the influence of hMSCs on the proliferation of lung cancer cell lines SK-MES-1 and A549 in vitro and in vivo by using a co-culture system and the hMSCs-conditioned medium. Our results demonstrated that hMSCs could inhibit the proliferation of SK-MES-1 and A549 cells, and induce the apoptosis of tumor cells in vitro via some soluble factors. Animal study showed that these soluble factors from hMSCs could suppress tumorigenesis and tumor angiogenesis by treating preliminarily tumor cells with the hMSCs-conditioned medium. The downregulated expression of vascular endothelial growth factor in tumor cells might be the mechanism of interference in tumor angiogenesis, which was verified by western blot analysis and immunohistochemistry assay. Taken together, our results suggested that the hMSCs could inhibit tumor cell growth by secreting some soluble factors.
Insights
Human mesenchymal stem cells (hMSCs) inhibit lung cancer cell growth and angiogenesis. These stem cells secrete soluble factors that suppress tumor development and vascularization, offering potential therapeutic strategies.
Area of Science:
- Oncology
- Stem Cell Biology
- Cancer Research
Background:
- Human mesenchymal stem cells (hMSCs) are recognized for their clinical potential.
- Emerging research highlights the role of hMSCs in cancer biology.
- Understanding hMSC interactions with cancer cells is crucial for therapeutic development.
Purpose of the Study:
- To investigate the effects of hMSCs on lung cancer cell proliferation in vitro and in vivo.
- To identify the mechanisms by which hMSCs influence tumor growth and angiogenesis.
- To explore the potential of hMSC-secreted factors in cancer therapy.
Main Methods:
- Co-culture systems and hMSC-conditioned medium were used to study hMSC-lung cancer cell interactions.
- In vitro assays assessed proliferation and apoptosis of SK-MES-1 and A549 lung cancer cell lines.
- In vivo animal studies evaluated the impact of hMSC factors on tumorigenesis and tumor angiogenesis.
- Western blot and immunohistochemistry assays analyzed vascular endothelial growth factor (VEGF) expression.
Main Results:
- hMSCs significantly inhibited the proliferation of SK-MES-1 and A549 lung cancer cells in vitro.
- hMSCs induced apoptosis in tumor cells through soluble factors.
- hMSC-conditioned medium suppressed tumor growth and angiogenesis in vivo.
- Downregulation of VEGF expression in tumor cells was identified as a key mechanism for inhibiting angiogenesis.
Conclusions:
- hMSCs possess anti-tumor properties against lung cancer cell lines.
- Soluble factors secreted by hMSCs play a critical role in inhibiting tumor cell growth and angiogenesis.
- hMSCs and their secreted factors represent a promising avenue for lung cancer treatment strategies.
